RxDoctor Payments Data

Sean McMillan, DO

Sports Medicine · Burlington, NJNPI 1689885816

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.4%), other and speaking fees — rather than concentrated in one kind of arrangement. 45 manufacturers reported payments, led by Linvatec Corporation at 43.0% of the total. Reporting peaked in 2022 at $626,442 and has fallen 63.5% since, to $228,358 in 2025. Among sports medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,831,093in general payments, 2019–2025

Across 848 payments — averaging $2159.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$787K
  • Davol Inc.$279K
  • Medical Device Business Services, Inc.$201K
  • Biorez, Inc.$100K
  • Miach Orthopaedics, Inc.$87K
  • Pacira Pharmaceuticals Incorporated$68K
  • plus $310K from 39 others
$680,006in research payments, 2019–2025

Across 44 payments — averaging $15,455 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Miach Orthopaedics, Inc.$306K
  • Medical Device Business Services, Inc.$275K
  • Anika Therapeutics, Inc.$49K
  • Biorez, Inc.$24K
  • Linvatec Corporation$24K
  • Smith+Nephew$2K
$486,150in ownership & investment interests, 2019–2025

Across 17 payments — averaging $28,597 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zurimed Technologies Inc.$251K
  • Spectrawave, Inc$235K
  • Trice Medical, Inc.$0

What the payments were for

  • Consulting fees$941,85251%
  • Speaking & faculty fees$275,81615%
  • Travel & lodging$63,7333%
  • Food & beverage$27,6932%
  • Education$8,6910%
  • Entertainment$470%
  • Other$513,26228%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Linvatec Corporation89$786,560
Davol Inc.124$279,240
Medical Device Business Services, Inc.128$200,789
Biorez, Inc.10$99,740
Miach Orthopaedics, Inc.20$87,136
Pacira Pharmaceuticals Incorporated53$68,011
Trice Medical, Inc.71$58,798
Anika Therapeutics, Inc.26$52,415
Johnson & Johnson(3 entities)48$38,274
Smith+Nephew28$25,756
Arthrex54$25,756
Zimmer Biomet38$18,602
Pristine Surgical LLC4$11,750
Vericel Corporation7$11,094
Exactech, Inc.3$10,629
Depuy Synthes Products, Inc.8$10,390
C. R. Bard, Inc. & Subsidiaries2$7,500
Prodigy Surgical Distribution, Inc.10$5,910
Zurimed Technologies Inc.12$5,492
Eclipse Technology Solutions Inc.23$5,247
Geistlich Pharma, North America, Inc.4$4,245
Ossio Inc3$3,230
Arcuro Medical Inc1$2,500
Pacira Therapeutics, Inc.13$2,348
Liberty Surgical Inc.4$2,110
Acelrx Pharmaceuticals, Inc.3$2,024
Stryker27$2,008
Maruho Medical, Inc.2$1,700
BD3$438
Integrity Orthopaedics, Inc.2$293
Paladin Technology Solutions1$279
Organogenesis Inc.3$251
Bard Access Systems, Inc.1$92
Brixton Biosciences, Inc.1$90
Novo Nordisk5$87
Bioventus LLC2$75
Innocoll Pharmaceuticals Limited3$58
Lundbeck LLC3$48
Ferring Pharmaceuticals Inc.2$27
Tenex Health Inc.2$24
Avanos Medical1$20
Kowa Pharmaceuticals America, Inc.1$17
Merck1$14
Shire North American Group Inc1$13
Amgen1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,831,093 in reported general payments places this provider in the 95th percentile of 221 sports medicine providers in New Jersey.

See all sports medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$205,128
Medicare patients
267
Services billed
4,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium27$1,529
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen127$436
Celecoxib35$393
Meloxicam108$303
Gabapentin20$239
Ibuprofen35$193
Naproxen22$144
Tramadol Hcl65$139
Pregabalin12$136
Methylprednisolone11$123
Cyclobenzaprine Hcl13$112
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$47
Amoxicillin12$19

Paid to pharmacies, not to this prescriber.

Other sports medicine in Burlington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →